BCL2 and breast carcinoma: This has been confirmed by other studies of prostate cancer34, renal cancer24, oropharyngeal squamous cell carcinoma35 and breast cancer36, although Zhang et al.14 have an opposite result showing that the −938A allele contributed to decreased expression of the BCL2 protein in breast cancer cell lines.